Skip to content
Home/Companies/Biotech/Cellectis

Cellectis

Biotech·France·Exited 2014·Held 12yr
Entry
2002
Hold
12yr
Exit
2014

Who owns Cellectis?

Cellectis was owned by Odyssée Venture through Odyssee Venture Funds (1999 vintage) from 2002 to 2014, exited via Secondary.

Hand-verified · updated 2026-05-21

Odyssée Venture
Investor
Odyssée Venture
Odyssee Venture Funds · 1999 · VC

Key facts

HQFrance
SectorBiotech
StatusAcquired
Exit Type
Secondary
Buyer
–
MOIC
–
Exit Year
2014

More from Odyssee Venture Funds

Other portfolio companies in the same fund.

Ausy
Exited 2017
IT ServicesFrance
to
DLSoftware
Exited 2017
SaaSFrance
to
Emme
Exited 2007
TMTFrance
to
EWave
Exited 2000
E-commerceFrance
to
Focus
Exited 2022
GamingFrance
HFCompany
HFCompany
Active
TelecomFrance

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Cellectis

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Cellectis?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Cellectis.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue